ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2601

Platelets Specifically Interact with Remigrating Neutrophils and Promote Immunogenic Cellular Death in Systemic Lupus

Marie nansion1, Eloi Schmauch2, Pierre Vacher3, Jean Sibilia4, Nathan Broussaudier1, Adeline Bruchon1, Pierre Grenot1, Anne-Sophie Korganow5, Thierry Martin5, Sophie Caillard6, Anna Duval6, Jacques-Eric Gottenberg7, Raphaël Carapito1, Séiamak Bahram1, Patrick Blanco8 and Marc Scherlinger9, 1UMR_INSERM 1109, Strasbourg, France, 2Broad Institute of MIT and Harvard, Cambridge, MA, USA., Boston, MA, 3Inserm U1045, Bordeaux, France, 4Strasbourg University Hospital, National reference center for autoimmune disease, Rheumatology, Strasbourg, France, 5Strasbourg University Hospital, National reference center for autoimmune disease, Clinical Immunology, Strasbourg, France, 6Nephrology department, HUS, Strasbourg, France, 7Rheumatology Department, Strasbourg University Hospital,, Strasbourg, France, 8UMR_CNRS 5164 Immunoconcept, BORDEAUX CEDEX, France, 9Strasbourg University Hospital; INSERM 1109, Strasbourg, France

Meeting: ACR Convergence 2024

Keywords: Adhesion, Adhesion molecules, Cell Death, Lupus nephritis, neutrophils, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: SLE – Etiology & Pathogenesis

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: In SLE, platelet activation (express P-selectin+) follows the disease activity, which plays a role in thrombosis as well as in inflammation (1). Neutrophils express high levels of PSGL-1, the ligand for P-selectin, which predicts a physical interaction between neutrophils and activated platelets in SLE patients. Our objective is to explore the relationships between platelets and neutrophils in human SLE.

Methods: We prospectively included SLE patients satisfying the 2019 ACR-EULAR criteria. Clinical data including disease activity (SLEDAI-2K; active SLE if SLEDAI ≥6) and immunological parameters were retrieved. We conducted spectral cytometry (Cytek Aurora) on fresh whole blood using a 37-color panel including platelets, neutrophils, and other immune surface markers. Neutrophils were CD66b+ cells identified on the SSC/FSC gating. Platelet-neutrophil aggregates (PNA) were identified as neutrophils coexpressing CD41a ± CD62P (P-selectin) platelet-specific markers. Using FlowJo v10, we conducted supervised and unsupervised analysis of neutrophils based on their interaction with platelets to explore neutrophils heterogeneity. In vitro experiments were conducted to investigate the signaling induced by P-selectin engagement on neutrophils and the impact on their phenotype.

Results: We recruited 50 patients with repeat samples for 8 patients. Platelet-neutrophil aggregates are increased in patients with active SLE compared to inactive SLE and healthy donors (p = 0.005 and p < 0.001, respectively). PNA positively correlate with the SLEDAI (Spearman’s r = 0,49; p = 0.003) and follows disease activity in longitudinal analyses.
A non supervised analysis identified that platelet-neutrophils aggregates have an atypical phenotype (ICAM1high, CXCR4high, CXCR1low; Fig. 1A), previously identified as activated neutrophils that remigrates from a peripheral tissue (ie, skin) to the kidney to induce tissue inflammation (2). We confirmed that these atypical neutrophils are increased in SLE patients (p < 0.05; Fig. 1B) and that these remigrant neutrophils preferentially aggregate with platelets (p < 0.0001; Fig. 1C). In vitro, P-selectin engagement on human neutrophils induces a PSGL-1/Syk/calcium/mitochondrialROS intracellular signalling which induces the upregulation of genes involved in NETosis (Fig 2A-C). Furthermore, P-selectin engagement promotes SLE-serum induced neutrophil death in vitro (p < 0.01; Fig 2D). Finally, in patients with lupus nephritis, scRNAseq whole-blood study successfully identified PNA and spatial transcriptomics (10X Visium) study of kidney biopsies is ongoing.

Conclusion: Platelet-neutrophil aggregates are increased in SLE and are enriched in an atypical subpopulation of neutrophils believed to remigrate to SLE target organs. Through P-selectin signalling, platelet promotes neutrophil immunogenic death in SLE and represents a novel therapeutic target.

References:

1) Scherlinger et al. Nat Rev Immunol 2023 Aug;23(8):495-510

2) Skopelja-Gardner et al. Proc. Natl. Acad. Sci. 2021 Jan 19;118(3):e2019097118.

Supporting image 1

ICAM1high CXCR4high CXCR1low neutrophils preferentially bind with platelets in SLE.
(A) UMAP of neutrophils from 20 active SLE patients showing expression patterns of platelet markers (CD41a & CD62p), adhesion marker/chemokine receptors (ICAM1, CXCR4, CXCR1) and receptors involved in neutrophil cell death (CD40, FAS). (B) Gating strategy and cumulative results of ICAM1high CXCR4high CXCR1low (remigrating) neutrophils in SLE patients. (C) Platelet neutrophil aggregates in total and remigrating neutrophils in SLE patients. *, p < 0.05 using Mann-Whitney test; ****, p < 0.0001 using Wilcoxon's test.

Supporting image 2

P-selectin engagement on neutrophils primes neutrophil immunogenic death. (A) 10^7 human neutrophils were cultured 8 hours with or without P-selectin 200ng/mL. After RNA extraction, RNAseq was conducted. Results showing the pathway enrichment analysis of the P-selectin culture condition. P-values are corrected for multiple analysis. (B) Human neutrophils were incubated with the Cali-520 calcium-sensitive fluorophore, and single-cell fluorescence was acquired real time using an epifluorescence microscope (Olympus, IX70) after P-selectin addition to the medium (200ng/mL). Neutrophils were preincubated with an anti-PSGL_1 antibody (red curve; clone KPL_1, 1/100) or a Syk inhibitor (blue curve; 1µM). (C) The same experience was conducted using the MitoSox mitochondrial reactive oxygen species (ROS) marker. (D) Human neutrophils were freshly sorted using MACSXpress and cultured overnight with autologous or SLE patient serum 20% ± P-selectin 20%. 7-AAD/Annexin staining shows the percentage of living cells at the end of the experiments. *, p < 0.05; **, p < 0.01 using paired ANOVA with correction for multiple analysis.


Disclosures: M. nansion: None; E. Schmauch: None; P. Vacher: None; J. Sibilia: None; N. Broussaudier: None; A. Bruchon: None; P. Grenot: None; A. Korganow: None; T. Martin: None; S. Caillard: None; A. Duval: None; J. Gottenberg: AbbVie, 2, BMS, 2, 5, Galapagos, 2, Gilead, 2, Lilly, 2, MSD, 2, Novartis, 2, Pfizer, 2, 5; R. Carapito: None; S. Bahram: None; P. Blanco: None; M. Scherlinger: Abbvie, 2, Amgen, 2, AstraZeneca, 2, Bristol-Myers Squibb(BMS), 2, Fresenius Kabi, 2, GlaxoSmithKlein(GSK), 2, Innate pharma, 2, Nordic Pharma, 2, Novartis, 2, Roche, 2, Sandoz, 2.

To cite this abstract in AMA style:

nansion M, Schmauch E, Vacher P, Sibilia J, Broussaudier N, Bruchon A, Grenot P, Korganow A, Martin T, Caillard S, Duval A, Gottenberg J, Carapito R, Bahram S, Blanco P, Scherlinger M. Platelets Specifically Interact with Remigrating Neutrophils and Promote Immunogenic Cellular Death in Systemic Lupus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/platelets-specifically-interact-with-remigrating-neutrophils-and-promote-immunogenic-cellular-death-in-systemic-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/platelets-specifically-interact-with-remigrating-neutrophils-and-promote-immunogenic-cellular-death-in-systemic-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology